TRIL

Trillium Therapeutics Inc.
TRIL

Overview Fund Activity
Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

26 hedge funds and large institutions have $53.1M invested in Trillium Therapeutics Inc. in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.

Holders
26
Holders Change
+6
Holders Change %
+30%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
7
Reduced
6
Closed
4
Calls
$256K
Puts
$171K
Net Calls
+$85K
Net Calls Change
+$85K

Top Buyers

1
MCMC
1
Matrix Capital Management Company
New Hampshire
$15.8M
2
NMC
2
NEA Management Company
Maryland
$9.06M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.14M
4
AG
4
Artal Group
Luxembourg
$1.09M
5
Deutsche Bank
5
Deutsche Bank
Germany
$835K

Top Sellers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$0
2
SAM
2
Sectoral Asset Management
Quebec, Canada
$0
3
AIC
3
AWM Investment Company
New York
$7.08M
4
TCM
4
Tekla Capital Management
Massachusetts
$3.29M
5
CS
5
Candriam SCA
Luxembourg
$683K
Name Holding Trade Value Shares
Change 		Shares
Change %
Janus Henderson Group
26
Janus Henderson Group
United Kingdom
– -$2.21M -429,262 Closed
SAM
27
Sectoral Asset Management
Quebec, Canada
– -$1.21M -234,248 Closed
UBS Group
28
UBS Group
Switzerland
– -$6K -1,230 Closed
Bank of America
29
Bank of America
North Carolina
– -$2K -400 Closed
1
2